Insights into Peptidoglycan-Targeting Radiotracers for Imaging Bacterial Infections: Updates, Challenges, and Future Perspectives
Overview
Microbiology
Pharmacology
Authors
Affiliations
The unique structural architecture of the peptidoglycan allows for the stratification of bacteria as either Gram-negative or Gram-positive, which makes bacterial cells distinguishable from mammalian cells. This classification has received attention as a potential target for diagnostic and therapeutic purposes. Bacteria's ability to metabolically integrate peptidoglycan precursors during cell wall biosynthesis and recycling offers an opportunity to target and image pathogens in their biological state. This Review explores the peptidoglycan biosynthesis for bacteria-specific targeting for infection imaging. Current and potential radiolabeled peptidoglycan precursors for bacterial infection imaging, their development status, and their performance and/or are highlighted. We conclude by providing our thoughts on how to shape this area of research for future clinical translation.
Koatale P, Welling M, Mdanda S, Mdlophane A, Takyi-Williams J, Durandt C Pharmaceuticals (Basel). 2024; 17(9).
PMID: 39338315 PMC: 11434960. DOI: 10.3390/ph17091150.
Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
Scott P, Penuelas I, Rey A, Aime S, Ambikalmajan P, Antunes I EJNMMI Radiopharm Chem. 2024; 9(1):67.
PMID: 39283414 PMC: 11405612. DOI: 10.1186/s41181-024-00296-6.
Preparation of a Zirconium-89 Labeled Clickable DOTA Complex and Its Antibody Conjugate.
Basuli F, Vasalatiy O, Shi J, Lane K, Escorcia F, Swenson R Pharmaceuticals (Basel). 2024; 17(4).
PMID: 38675440 PMC: 11053460. DOI: 10.3390/ph17040480.